COVID-19 and Aggressive Lymphoma: Frequently Asked Questions Answered by ASH

The American Society of Hematology (ASH) provides answers to frequently asked questions regarding the management of patients with diffuse large B-cell lymphoma (DLBCL) amid the COVID-19 era, including treatment, infection prevention, and vaccination. 

https://www.hematology.org/covid-19/covid-19-and-aggressive-lymphoma

---